The UAE has strongly condemned the terrorist attack that took place in eastern Democratic Republic of the Congo and killed more than 100 people.In a statement, the Ministry of Foreign Affairs and International Cooperation (MoFAIC) affirmed that the UAE…
The Safety & Security Operations Committee (SSOC) of the FIFA World Cup Qatar 2022™ – in a press release on its official Twitter account yesterday – noted that all fans must obtain approved tickets for matches they want to attend in any stadiums. …
The Communications Regulatory Authority (CRA) has issued more than 25,000 authorizations for radio applications and equipment allowing the host country, the International Federation of Association Football (FIFA), FIFA contractors, FIFA commercial affi…
The Ministry of Transport’s statistics revealed that record numbers were achieved in terms of air traffic performance and internal transportation services since the start of the FIFA World Cup Qatar 2022, until the end of the group matches of the tourn…
President His Highness Sheikh Mohamed bin Zayed Al Nahyan has received cables of congratulations from kings, presidents and emirs of brotherly and friendly countries on the UAE’s 51st National Day.His Highness Sheikh Mohammed bin Rashid Al Maktoum, Vic…
President His Highness Sheikh Mohamed bin Zayed Al Nahyan has sent a message of congratulations to President Thongloun Sisoulith of the People’s Democratic Republic of Laos, on the occasion of his country’s National Day.His Highness Sheikh Mohammed bin…
The UAE has strongly condemned the attempted assassination of the head of mission of the Islamic Republic of Pakistan in the Afghan capital, Kabul, stressing the need to protect diplomatic missions and buildings in accordance with the norms and charter…
BERLIN, CAIRO and DUBAI, UAE, Nov. 30, 2022 /PRNewswire/ — Bioventure, a Dubai-based pharmaceutical company, Minapharm Pharmaceuticals, a Cairo-based pharmaceutical company, and MiGenTra GmbH, a Berlin-based pharmaceutical company, announced today the signing of an exclusive license agreement for the commercialization of multiple biosimilar candidates developed and manufactured by Alvotech, in Egypt and eighteen additional countries in Africa and the Middle